An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis

Tahera Zabuawala1, David A Taffany, Sudarshana M Sharma

  • 1Department of Molecular and Cellular Biochemistry, Center for Biostatistics, College of Public Health, and Tumor Microenvironment Program, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA.

Cancer Research
|February 11, 2010
PubMed

Insights

Transcription factor Ets2 in tumor-associated macrophages (TAMs) drives breast cancer metastasis by repressing anti-angiogenic genes. Inhibiting Ets2 in TAMs reduced tumor growth and spread, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) play a critical role in breast cancer metastasis.
  • The specific genes and pathways regulated by TAMs in metastasis are not fully understood.
  • Ets2 is a transcription factor involved in macrophage function and inflammation.

Purpose of the Study:

  • To investigate the role of Ets2 in TAMs during breast cancer growth and metastasis.
  • To identify the downstream targets and mechanisms by which Ets2 influences metastasis.

Main Methods:

  • Conditional deletion of Ets2 in TAMs in mouse models of breast cancer.
  • Gene expression profiling and chromatin immunoprecipitation assays on isolated TAMs.
  • Analysis of angiogenesis, tumor growth, and lung metastasis.
  • Identification and validation of an Ets2-TAM expression signature in human breast cancer data.

Main Results:

  • Ets2 deletion in TAMs significantly reduced lung metastasis frequency and size in multiple mouse models.
  • Ets2 was found to repress a gene program including angiogenesis inhibitors.
  • Ablation of Ets2 in TAMs led to decreased angiogenesis and tumor growth.
  • An Ets2-TAM signature of 133 genes predicted patient survival in human breast cancer datasets.

Conclusions:

  • Ets2 is a key driver of a transcriptional program in TAMs that promotes breast cancer lung metastasis.
  • Ets2 regulates angiogenesis and tumor growth through its effects on TAMs.
  • The identified Ets2-TAM signature serves as a potential biomarker for breast cancer prognosis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...